Tympner F
Z Gastroenterol. 1981 Nov;19(11):708-11.
Non-steroid antirheumatic drugs inhibit the synthesis of prostaglandin, which results in a reduction in the efficacy of the gastric mucosal barrier. The transmural electric potential difference of the stomach wall would appear to be a useful criterion for mucosal barrier function. After 4 weeks of treatment with Indomethacin, Azapropazpone, Diclofenac or Phenylbutazone, a significant reduction in the gastric potential difference as compared with the pre-treatment measurement was observed. Accordingly, non-steroid antirheumatics give rise to a reduction in the functional efficacy of the mucosal barrier.
非甾体类抗风湿药物抑制前列腺素的合成,这会导致胃黏膜屏障功能降低。胃壁的跨膜电位差似乎是衡量黏膜屏障功能的一个有用标准。在用吲哚美辛、阿扎丙宗、双氯芬酸或保泰松治疗4周后,观察到与治疗前测量值相比,胃电位差显著降低。因此,非甾体类抗风湿药物会导致黏膜屏障功能效率降低。